Antibiotics losing the fight against infection
In New York a patient with a severe abdominal infection survived after the FDA allowed an untested antibiotic pristinamycin, highlighting a rising global threat as bacteria grow resistance to penicillin, vancomycin, and other drugs. Experts warn of a postantibiotic era, with few new antibiotics on the horizon and resistance spreading from hospitals to the community.
MENTIONED IN THIS ARTICLE
New York
Jim Rahal
Food and Drug Administration
United States
FDA
Rahal
Infectious Disease Center
New York Hospital Medical Center
Queens
Boston
William Stewart
Stuart B. Levy
Tufts University
Stewart
Levy
Chris Foreman
Brookings Institution
Washington
Foreman
America
Pharmaceutical Research and Manufacturers of America
Sheldon Kaplan
Texas Children’s Hospital
Houston
Also Mentioned on This Page
Centers For Disease Control and Prevention
CDC
JAMA
MYTH
the Real Estate Institute
Kelso-Wheeler & Associates, Inc
George Afetrehuam
Rodent Superior
U.S. Marine Corps
U.S. Coast Guard Reserve
Wake Forest School of Law
Morehead
First Presbyterian Church
Wainwright
Chateau Monroe
Pollock St
New Bern
Antczak
Robert
Brandi Darnell
Public Works Department
Pfaltzgraff
Lk, Poe
Independence Mall
Wilmington
Jacksonville
Twin Rivers
Morehead Plaza
Morehead City